Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)
(S)-10-(2,6-Dimethyl-4-pyridinyl) 9-fluoro-3-methyl-7-oxo 2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzothiazine-6-carboxylic acid (WIN 58161) is an enantiomerically pure quinolone with outstanding bacterial topoisomerase II (DNA gyrase, EC 5.99.1.3) inhibitory and antibacterial activity. Unlike most qu...
Gespeichert in:
| Veröffentlicht in: | Biochemical pharmacology 1995-06, Vol.50 (1), p.111-122 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 122 |
|---|---|
| container_issue | 1 |
| container_start_page | 111 |
| container_title | Biochemical pharmacology |
| container_volume | 50 |
| creator | COUGHLIN, S. A DANZ, D. W RAKE, J. B ROBINSON, R. G KLINGBEIL, K. M WENTLAND, M. P CORBETT, T. H WAUD, W. R ZWELLING, L. A ALTSCHULER, E BALES, E |
| description | (S)-10-(2,6-Dimethyl-4-pyridinyl) 9-fluoro-3-methyl-7-oxo 2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzothiazine-6-carboxylic acid (WIN 58161) is an enantiomerically pure quinolone with outstanding bacterial topoisomerase II (DNA gyrase, EC 5.99.1.3) inhibitory and antibacterial activity. Unlike most quinolones, WIN 58161 also exhibits significant inhibitory activity against mammalian topoisomerase II (EC 5.99.1.3). DNA gyrase and topoisomerase II inhibitory activities are enantioselective. Consequently, WIN 58161 and its enantiomer (WIN 58161-2) provide useful tools to probe the contribution of topoisomerase II inhibition to the mechanism of cytotoxicity of quinolones and the potential utility of quinolone-topoisomerase II inhibitors as antitumor agents. WIN 58161 inhibited both highly purified Escherichia coli DNA gyrase and HeLa cell topoisomerase II by the promotion of enzyme-DNA covalent complexes. WIN 58161 did not bind stably to DNA via intercalation and did not enhance the formation of topoisomerase I (EC 5.99.1.2)-DNA covalent complexes. At drug concentrations that are cytotoxic to P388 murine leukemia cells, WIN 58161 promoted intracellular DNA single-strand breaks (SSBs) that exhibited the hallmarks of being mediated by topoisomerase. DNA fragments were complexed with protein, and SSBs were readily resealed at 37 degree following drug removal. WIN 58161-2 was neither cytotoxic nor did it promote intracellular SSBs in P388. These observations suggest that the mechanism of cytotoxicity of WIN 58161 is predominantly, if not exclusively, a result of topoisomerase II inhibition. When studied in tumor-bearing mice, WIN 58161 exhibited a significant antitumor effect against each of five tumors tested, whereas neither toxicity nor antitumor activity was observed with WIN 58161-2. We conclude from these studies that WIN 58161 represents the prototype of a novel chemical class of topoisomerase II inhibitor with potential clinical utility in treating cancer. |
| doi_str_mv | 10.1016/0006-2952(95)00016-S |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_15565876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15565876</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-d4ab3ee34c3384f000dbc57f3d221aec5b132c5026695803f9ab5c083aebec213</originalsourceid><addsrcrecordid>eNo9Uctq3DAUFaGBTJP-QRZehDIDc1M9LNleltA8II_FtHRRgpBlmVGRrankKXH-LH8XeWbI4qJ773kg6SB0TvAlwUR8wxgLoBWn84ov0kAErI7QjJQFS2tRfkKzD8oJ-hzj32ksBZmhtwej16q3sct8myk9WN9nqm9SDXbYdj7slv_tME6E-WoBBMOcLgU0tjPDenSQw2YMtrH96BZQQeu2PnhgcIAL8C8e6JIlxXpsElTc7hXe_SHLHWCeIbX5c236Vz-srXq1vQEBWoXav4zO6nQN22Tz33ePGS-JIIszdNwqF82Xw3mKfl3_-Hl1C_dPN3dX3-9BM1wN0OSqZsawXDNW5m16eFNrXrSsoZQoo3lNGNUcUyEqXmLWVqrmGpdMmdpoStgp-rr33QT_b2viIDsbtXFO9cZvoyScC14WIhHzPVEHH2MwrdwE26kwSoLllJOcfl1OIciKy11OcpVkFwd_FbVybVC9tvFDywTGrGDsHUpmkFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15565876</pqid></control><display><type>article</type><title>Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>COUGHLIN, S. A ; DANZ, D. W ; RAKE, J. B ; ROBINSON, R. G ; KLINGBEIL, K. M ; WENTLAND, M. P ; CORBETT, T. H ; WAUD, W. R ; ZWELLING, L. A ; ALTSCHULER, E ; BALES, E</creator><creatorcontrib>COUGHLIN, S. A ; DANZ, D. W ; RAKE, J. B ; ROBINSON, R. G ; KLINGBEIL, K. M ; WENTLAND, M. P ; CORBETT, T. H ; WAUD, W. R ; ZWELLING, L. A ; ALTSCHULER, E ; BALES, E</creatorcontrib><description>(S)-10-(2,6-Dimethyl-4-pyridinyl) 9-fluoro-3-methyl-7-oxo 2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzothiazine-6-carboxylic acid (WIN 58161) is an enantiomerically pure quinolone with outstanding bacterial topoisomerase II (DNA gyrase, EC 5.99.1.3) inhibitory and antibacterial activity. Unlike most quinolones, WIN 58161 also exhibits significant inhibitory activity against mammalian topoisomerase II (EC 5.99.1.3). DNA gyrase and topoisomerase II inhibitory activities are enantioselective. Consequently, WIN 58161 and its enantiomer (WIN 58161-2) provide useful tools to probe the contribution of topoisomerase II inhibition to the mechanism of cytotoxicity of quinolones and the potential utility of quinolone-topoisomerase II inhibitors as antitumor agents. WIN 58161 inhibited both highly purified Escherichia coli DNA gyrase and HeLa cell topoisomerase II by the promotion of enzyme-DNA covalent complexes. WIN 58161 did not bind stably to DNA via intercalation and did not enhance the formation of topoisomerase I (EC 5.99.1.2)-DNA covalent complexes. At drug concentrations that are cytotoxic to P388 murine leukemia cells, WIN 58161 promoted intracellular DNA single-strand breaks (SSBs) that exhibited the hallmarks of being mediated by topoisomerase. DNA fragments were complexed with protein, and SSBs were readily resealed at 37 degree following drug removal. WIN 58161-2 was neither cytotoxic nor did it promote intracellular SSBs in P388. These observations suggest that the mechanism of cytotoxicity of WIN 58161 is predominantly, if not exclusively, a result of topoisomerase II inhibition. When studied in tumor-bearing mice, WIN 58161 exhibited a significant antitumor effect against each of five tumors tested, whereas neither toxicity nor antitumor activity was observed with WIN 58161-2. We conclude from these studies that WIN 58161 represents the prototype of a novel chemical class of topoisomerase II inhibitor with potential clinical utility in treating cancer.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(95)00016-S</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Biochemical pharmacology, 1995-06, Vol.50 (1), p.111-122</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c309t-d4ab3ee34c3384f000dbc57f3d221aec5b132c5026695803f9ab5c083aebec213</citedby><cites>FETCH-LOGICAL-c309t-d4ab3ee34c3384f000dbc57f3d221aec5b132c5026695803f9ab5c083aebec213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3600373$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>COUGHLIN, S. A</creatorcontrib><creatorcontrib>DANZ, D. W</creatorcontrib><creatorcontrib>RAKE, J. B</creatorcontrib><creatorcontrib>ROBINSON, R. G</creatorcontrib><creatorcontrib>KLINGBEIL, K. M</creatorcontrib><creatorcontrib>WENTLAND, M. P</creatorcontrib><creatorcontrib>CORBETT, T. H</creatorcontrib><creatorcontrib>WAUD, W. R</creatorcontrib><creatorcontrib>ZWELLING, L. A</creatorcontrib><creatorcontrib>ALTSCHULER, E</creatorcontrib><creatorcontrib>BALES, E</creatorcontrib><title>Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)</title><title>Biochemical pharmacology</title><description>(S)-10-(2,6-Dimethyl-4-pyridinyl) 9-fluoro-3-methyl-7-oxo 2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzothiazine-6-carboxylic acid (WIN 58161) is an enantiomerically pure quinolone with outstanding bacterial topoisomerase II (DNA gyrase, EC 5.99.1.3) inhibitory and antibacterial activity. Unlike most quinolones, WIN 58161 also exhibits significant inhibitory activity against mammalian topoisomerase II (EC 5.99.1.3). DNA gyrase and topoisomerase II inhibitory activities are enantioselective. Consequently, WIN 58161 and its enantiomer (WIN 58161-2) provide useful tools to probe the contribution of topoisomerase II inhibition to the mechanism of cytotoxicity of quinolones and the potential utility of quinolone-topoisomerase II inhibitors as antitumor agents. WIN 58161 inhibited both highly purified Escherichia coli DNA gyrase and HeLa cell topoisomerase II by the promotion of enzyme-DNA covalent complexes. WIN 58161 did not bind stably to DNA via intercalation and did not enhance the formation of topoisomerase I (EC 5.99.1.2)-DNA covalent complexes. At drug concentrations that are cytotoxic to P388 murine leukemia cells, WIN 58161 promoted intracellular DNA single-strand breaks (SSBs) that exhibited the hallmarks of being mediated by topoisomerase. DNA fragments were complexed with protein, and SSBs were readily resealed at 37 degree following drug removal. WIN 58161-2 was neither cytotoxic nor did it promote intracellular SSBs in P388. These observations suggest that the mechanism of cytotoxicity of WIN 58161 is predominantly, if not exclusively, a result of topoisomerase II inhibition. When studied in tumor-bearing mice, WIN 58161 exhibited a significant antitumor effect against each of five tumors tested, whereas neither toxicity nor antitumor activity was observed with WIN 58161-2. We conclude from these studies that WIN 58161 represents the prototype of a novel chemical class of topoisomerase II inhibitor with potential clinical utility in treating cancer.</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNo9Uctq3DAUFaGBTJP-QRZehDIDc1M9LNleltA8II_FtHRRgpBlmVGRrankKXH-LH8XeWbI4qJ773kg6SB0TvAlwUR8wxgLoBWn84ov0kAErI7QjJQFS2tRfkKzD8oJ-hzj32ksBZmhtwej16q3sct8myk9WN9nqm9SDXbYdj7slv_tME6E-WoBBMOcLgU0tjPDenSQw2YMtrH96BZQQeu2PnhgcIAL8C8e6JIlxXpsElTc7hXe_SHLHWCeIbX5c236Vz-srXq1vQEBWoXav4zO6nQN22Tz33ePGS-JIIszdNwqF82Xw3mKfl3_-Hl1C_dPN3dX3-9BM1wN0OSqZsawXDNW5m16eFNrXrSsoZQoo3lNGNUcUyEqXmLWVqrmGpdMmdpoStgp-rr33QT_b2viIDsbtXFO9cZvoyScC14WIhHzPVEHH2MwrdwE26kwSoLllJOcfl1OIciKy11OcpVkFwd_FbVybVC9tvFDywTGrGDsHUpmkFA</recordid><startdate>19950629</startdate><enddate>19950629</enddate><creator>COUGHLIN, S. A</creator><creator>DANZ, D. W</creator><creator>RAKE, J. B</creator><creator>ROBINSON, R. G</creator><creator>KLINGBEIL, K. M</creator><creator>WENTLAND, M. P</creator><creator>CORBETT, T. H</creator><creator>WAUD, W. R</creator><creator>ZWELLING, L. A</creator><creator>ALTSCHULER, E</creator><creator>BALES, E</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19950629</creationdate><title>Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)</title><author>COUGHLIN, S. A ; DANZ, D. W ; RAKE, J. B ; ROBINSON, R. G ; KLINGBEIL, K. M ; WENTLAND, M. P ; CORBETT, T. H ; WAUD, W. R ; ZWELLING, L. A ; ALTSCHULER, E ; BALES, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-d4ab3ee34c3384f000dbc57f3d221aec5b132c5026695803f9ab5c083aebec213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>COUGHLIN, S. A</creatorcontrib><creatorcontrib>DANZ, D. W</creatorcontrib><creatorcontrib>RAKE, J. B</creatorcontrib><creatorcontrib>ROBINSON, R. G</creatorcontrib><creatorcontrib>KLINGBEIL, K. M</creatorcontrib><creatorcontrib>WENTLAND, M. P</creatorcontrib><creatorcontrib>CORBETT, T. H</creatorcontrib><creatorcontrib>WAUD, W. R</creatorcontrib><creatorcontrib>ZWELLING, L. A</creatorcontrib><creatorcontrib>ALTSCHULER, E</creatorcontrib><creatorcontrib>BALES, E</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>COUGHLIN, S. A</au><au>DANZ, D. W</au><au>RAKE, J. B</au><au>ROBINSON, R. G</au><au>KLINGBEIL, K. M</au><au>WENTLAND, M. P</au><au>CORBETT, T. H</au><au>WAUD, W. R</au><au>ZWELLING, L. A</au><au>ALTSCHULER, E</au><au>BALES, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161)</atitle><jtitle>Biochemical pharmacology</jtitle><date>1995-06-29</date><risdate>1995</risdate><volume>50</volume><issue>1</issue><spage>111</spage><epage>122</epage><pages>111-122</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>(S)-10-(2,6-Dimethyl-4-pyridinyl) 9-fluoro-3-methyl-7-oxo 2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzothiazine-6-carboxylic acid (WIN 58161) is an enantiomerically pure quinolone with outstanding bacterial topoisomerase II (DNA gyrase, EC 5.99.1.3) inhibitory and antibacterial activity. Unlike most quinolones, WIN 58161 also exhibits significant inhibitory activity against mammalian topoisomerase II (EC 5.99.1.3). DNA gyrase and topoisomerase II inhibitory activities are enantioselective. Consequently, WIN 58161 and its enantiomer (WIN 58161-2) provide useful tools to probe the contribution of topoisomerase II inhibition to the mechanism of cytotoxicity of quinolones and the potential utility of quinolone-topoisomerase II inhibitors as antitumor agents. WIN 58161 inhibited both highly purified Escherichia coli DNA gyrase and HeLa cell topoisomerase II by the promotion of enzyme-DNA covalent complexes. WIN 58161 did not bind stably to DNA via intercalation and did not enhance the formation of topoisomerase I (EC 5.99.1.2)-DNA covalent complexes. At drug concentrations that are cytotoxic to P388 murine leukemia cells, WIN 58161 promoted intracellular DNA single-strand breaks (SSBs) that exhibited the hallmarks of being mediated by topoisomerase. DNA fragments were complexed with protein, and SSBs were readily resealed at 37 degree following drug removal. WIN 58161-2 was neither cytotoxic nor did it promote intracellular SSBs in P388. These observations suggest that the mechanism of cytotoxicity of WIN 58161 is predominantly, if not exclusively, a result of topoisomerase II inhibition. When studied in tumor-bearing mice, WIN 58161 exhibited a significant antitumor effect against each of five tumors tested, whereas neither toxicity nor antitumor activity was observed with WIN 58161-2. We conclude from these studies that WIN 58161 represents the prototype of a novel chemical class of topoisomerase II inhibitor with potential clinical utility in treating cancer.</abstract><cop>New York, NY</cop><pub>Elsevier Science</pub><doi>10.1016/0006-2952(95)00016-S</doi><tpages>12</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-2952 |
| ispartof | Biochemical pharmacology, 1995-06, Vol.50 (1), p.111-122 |
| issn | 0006-2952 1873-2968 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_15565876 |
| source | ScienceDirect Journals (5 years ago - present) |
| subjects | Antineoplastic agents Biological and medical sciences Chemotherapy Medical sciences Pharmacology. Drug treatments |
| title | Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A23%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20of%20action%20and%20antitumor%20activity%20of%20(S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol%5B1,2,3-de%5D-%5B1,4%5Dbenzothiazine-6-carboxylic%20acid%20(WIN%2058161)&rft.jtitle=Biochemical%20pharmacology&rft.au=COUGHLIN,%20S.%20A&rft.date=1995-06-29&rft.volume=50&rft.issue=1&rft.spage=111&rft.epage=122&rft.pages=111-122&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(95)00016-S&rft_dat=%3Cproquest_cross%3E15565876%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15565876&rft_id=info:pmid/&rfr_iscdi=true |